Review article: non-alcoholic fatty liver disease and osteoporosis - clinical and molecular crosstalk

Association between Nonalcoholic Fatty Liver Disease (NAFLD) and Osteoporotic Fracture in Middle-Aged and Elderly Chinese

(2012) Mian Li et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The diagnosis of non-alcoholic fatty liver disease

(2011) N. Wlazlo et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

(2011) G. Vernon et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Non-alcoholic fatty liver disease is associated with low bone mineral density in obese children

(2011) P. E. Pardee et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Serum fetuin-A is correlated with metabolic syndrome in middle-aged and elderly Chinese

(2011) Yu Xu et al.   ATHEROSCLEROSIS

Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes

(2011) Ilaria Barchetta et al.   BMC Medicine

Fetuin-A Regulation of Calcified Matrix Metabolism

(2011) Willi Jahnen-Dechent et al.   CIRCULATION RESEARCH

Correlation of insulin sensitivity with bone mineral status in obese adolescents with nonalcoholic fatty liver disease

(2011) Ozgur Pirgon et al.   CLINICAL ENDOCRINOLOGY

Levels of fetuin-A relate to the levels of bone turnover biomarkers in male and female patients with type 2 diabetes

(2011) Sazan Rasul et al.   CLINICAL ENDOCRINOLOGY

Osteoprotegerin and Diabetes-Associated Pathologies

(2011) A. M. Blazquez-Medela et al.   CURRENT MOLECULAR MEDICINE

Osteocalcin: a new link between bone and energy metabolism. Some evolutionary clues

(2011) Jose M Fernández-Real et al.   CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE

Osteopontin deficiency protects against obesity-induced hepatic steatosis and attenuates glucose production in mice

(2011) F. W. Kiefer et al.   DIABETOLOGIA

The role of osteocalcin in the endocrine cross-talk between bone remodelling and energy metabolism

(2011) P. Ducy   DIABETOLOGIA

Association between bone mineral density and metabolic syndrome in pre- and postmenopausal women

(2011) Yun Kyung Jeon et al.   ENDOCRINE JOURNAL

Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies

(2011) John Willy Haukeland et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Acidic bone matrix proteins and their roles in calcification

(2011) Ryuichi Fujisawa   Frontiers in Bioscience-Landmark

Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and toll-like receptor activation

(2011) Christian L. Roth et al.   HEPATOLOGY

Hedgehog Signaling Antagonist Promotes Regression of Both Liver Fibrosis and Hepatocellular Carcinoma in a Murine Model of Primary Liver Cancer

(2011) George M. Philips et al.   PLoS One

Serum osteocalcin levels in patients with nonalcoholic fatty liver disease: Association with ballooning degeneration

(2011) Yusuf Yilmaz et al.   SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION

Nutrition and physical activity in NAFLD: An overview of the epidemiological evidence

(2011) Shira Zelber-Sagi   WORLD JOURNAL OF GASTROENTEROLOGY

Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease

(2010) N. J. BARSHOP et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Negative Association between Metabolic Syndrome and Bone Mineral Density in Koreans, Especially in Men

(2010) Ha Young Kim et al.   CALCIFIED TISSUE INTERNATIONAL

Enhanced expression of pro-inflammatory mediators and liver X-receptor-regulated lipogenic genes in non-alcoholic fatty liver disease and hepatitis C

(2010) Elena Lima-Cabello et al.   CLINICAL SCIENCE

Nonalcoholic Fatty Liver Disease

(2010) Kathryn Law et al.   Clinics in Liver Disease

Osteopontin; as a Target Molecule for the Treatment of Inflammatory Diseases

(2010) Junko Morimoto et al.   CURRENT DRUG TARGETS

Serum 25-Hydroxy Vitamin D and Insulin Resistance, Metabolic Syndrome, and Glucose Intolerance Among Arab Americans

(2010) N. R. Pinelli et al.   DIABETES CARE

Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis

(2010) Wing-Kin Syn et al.   HEPATOLOGY

Osteopontin: A missing link between hedgehog signaling and fibrosis in nonalcoholic steatohepatitis

(2010) Mariana Verdelho Machado et al.   HEPATOLOGY

Low Vitamin D Levels in Northern American Adults with the Metabolic Syndrome

(2010) S. Devaraj et al.   HORMONE AND METABOLIC RESEARCH

Men with metabolic syndrome have lower bone mineral density but lower fracture risk-the MINOS study

(2010) Pawel Szulc et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Impact of artificial sunlight therapy on the progress of non-alcoholic fatty liver disease in rats

(2010) Toshiaki Nakano et al.   JOURNAL OF HEPATOLOGY

Effects of physical activity on bone remodeling

(2010) Laurent Maïmoun et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Circulating osteocalcin concentrations are associated with parameters of liver fat infiltration and increase in parallel to decreased liver enzymes after weight loss

(2010) J. M. Fernández-Real et al.   OSTEOPOROSIS INTERNATIONAL

Osteopontin regulates anabolic effect in human menopausal osteoporosis with intermittent parathyroid hormone treatment

(2010) T.-I. Chiang et al.   OSTEOPOROSIS INTERNATIONAL

The relationship of fetuin-A and lactoferrin with bone mass in elderly women

(2010) L. Chailurkit et al.   OSTEOPOROSIS INTERNATIONAL

Increased serum osteopontin is a risk factor for osteoporosis in menopausal women

(2010) I.-C. Chang et al.   OSTEOPOROSIS INTERNATIONAL

Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome

(2010) J. Bernadette Moore   PROCEEDINGS OF THE NUTRITION SOCIETY

Serum levels of osteoprotegerin in the spectrum of nonalcoholic fatty liver disease

(2010) Yusuf Yilmaz et al.   SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION

Histopathology of nonalcoholic fatty liver disease

(2010) Elizabeth M Brunt   WORLD JOURNAL OF GASTROENTEROLOGY

Serum fetuin A/ 2HS-glycoprotein levels in patients with non-alcoholic fatty liver disease: relation with liver fibrosis

(2010) Y. Yilmaz et al.   ANNALS OF CLINICAL BIOCHEMISTRY

Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications

(2009) Elisa Fabbrini et al.   HEPATOLOGY

Vitamin D: emerging new roles in insulin sensitivity

(2009) Dorothy Teegarden et al.   NUTRITION RESEARCH REVIEWS

The effects of exercise and physical activity participation on bone mass and geometry in postmenopausal women: a systematic review of pQCT studies

(2009) C. J. Hamilton et al.   OSTEOPOROSIS INTERNATIONAL

Review article: diagnosis and treatment of non-alcoholic fatty liver disease

(2008) M. K. OH et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Pathophysiological roles of osteoprotegerin (OPG)

(2008) Penny Reid et al.   EUROPEAN JOURNAL OF CELL BIOLOGY

Fetuin-A and Its Relation to Metabolic Syndrome and Fatty Liver Disease in Obese Children Before and After Weight Loss

(2008) Thomas Reinehr et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Serum tumor necrosis factor-alpha concentrations are negatively correlated with serum 25(OH)D concentrations in healthy women

(2008) Catherine A Peterson et al.   Journal of Inflammation-London

Osteocalcin differentially regulates β cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice

(2008) Mathieu Ferron et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA